2,000
Participants
Start Date
July 31, 2022
Primary Completion Date
February 29, 2032
Study Completion Date
February 29, 2032
Pharmacogenomic testing of a panel of important pharmacogenes to detect genetic variants and evaluate the association between genetically predicted and measured drug metabolism
All planned interventions are explorative analyses of biological and genetic risk profiles that can contribute to patients' individual risk for adverse drug reactions, i.e. due to variability in drug metabolism
Adverse Drug Reaction detection
During appointments in the university outpatient clinic, patients will undergo a comprehensive adverse drug reaction (ADR) assessment based on an ADR diary they were handed at enrolment
Falls Efficacy Scale International (FES-I)
The FES-I wil be obtained to estimate fear of falling
B. Braun Foundation
OTHER
RWTH Aachen University
OTHER